Matthew I Callahan

US Patent:

20140065219, Mar 6, 2014

Filed:

Feb 28, 2013

Appl. No.:

13/781115

Inventors:

William H. Bosch - Bryn Mawr PA, US
Matthew Callahan - Philadelphia PA, US
Felix Meiser - Claremont, AU
Marck Norret - Darlington, AU
Adrian Russell - Rivervale, AU

International Classification:

A61J 3/02

US Classification:

424489, 514653, 514304

Abstract:

Methods for making inhalable composite particles comprising a pharmaceutically-active agent, the method comprising: a) providing composite particles comprising a millable grinding matrix and a solid pharmaceutically-active agent, wherein the pharmaceutically-active agent has an median particle size on a volume average basis between 50 nm and 3 μm; and b) milling the composite particles in a mill without milling bodies for a time period sufficient to produce inhalable composite particles having a mass median aerodynamic diameter between 1 μm and 20 μm are described.

US Patent:

20190224137, Jul 25, 2019

Filed:

Jan 24, 2019

Appl. No.:

16/257031

Inventors:

- Plymouth Meeting PA, US
Matthew Callahan - Haverford PA, US

Assignee:

Botanix Pharmaceuticals Ltd. - Plymouth Meeting PA

International Classification:

A61K 31/047
A61P 17/10
A61K 9/06
A61K 9/00
A61K 47/24
A61K 47/10

Abstract:

A method for treat acne comprising administering between 50 mg and 3000 mg of a topical liquid or gel composition comprising between 1% w/w and 15% w/w cannabinoid, wherein the cannabinoid is dissolved in the liquid or gel composition is described.

US Patent:

20190008874, Jan 10, 2019

Filed:

Jul 10, 2018

Appl. No.:

16/031686

Inventors:

- Sharjah, AE
Paul Nemeth - Philadelphia PA, US
H. William Bosch - Philadelphia PA, US
Matthew Callahan - Philadelphia PA, US
Satya Bhamidipati - Philadelphia PA, US
Jason Coleman - Philadelphia PA, US
Christopher Hill - Philadelphia PA, US
Marck Norret - Darlington, AU

International Classification:

A61K 31/58
A61K 31/573
A61K 31/19
A61K 9/20
A61K 9/14

Abstract:

Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.

US Patent:

20180318170, Nov 8, 2018

Filed:

Jul 16, 2018

Appl. No.:

16/036595

Inventors:

- Iluka, AU
Matthew Callahan - Philadelphia PA, US
Felix Meiser - Claremont, AU
Marck Norret - Darlington, AU
Adrian Russell - Rivervale, AU

International Classification:

A61J 3/02
A61K 31/137
A61K 31/46
A61K 9/00

Abstract:

Methods for making inhalable composite particles comprising a pharmaceutically-active agent, the method comprising: a) providing composite particles comprising a millable grinding matrix and a solid pharmaceutically-active agent, wherein the pharmaceutically-active agent has an median particle size on a volume average basis between 50 nm and 3 μm; and b) milling the composite particles in a mill without milling bodies for a time period sufficient to produce inhalable composite particles having a mass median aerodynamic diameter between 1 μm and 20 μm are described.

US Patent:

20170348328, Dec 7, 2017

Filed:

Jul 10, 2017

Appl. No.:

15/645895

Inventors:

- Philadelphia PA, US
Paul Nemeth - Philadelphia PA, US
H. William Bosch - Philadelphia PA, US
Matthew Callahan - Philadelphia PA, US
Satya Bhamidipati - Philadelphia PA, US
Jason Coleman - Philadelphia PA, US
Christopher Hill - Philadelphia PA, US
Marck Norret - Darlington, AU

International Classification:

A61K 31/58
A61K 9/20
A61K 31/573
A61K 31/19
A61K 9/14

Abstract:

Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.

US Patent:

20150246060, Sep 3, 2015

Filed:

May 8, 2015

Appl. No.:

14/707922

Inventors:

- Philadelphia PA, US
Paul Nemeth - Philadelphia PA, US
H. William Bosch - Philadelphia PA, US
Matthew Callahan - Philadelphia PA, US
Satya Bhamidipati - Philadelphia PA, US
Jason Coleman - Philadelphia PA, US
Christopher Hill - Philadelphia PA, US

International Classification:

A61K 31/58
A61K 31/19
A61K 31/573

Abstract:

Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.